Melanoma Research

Skip Navigation LinksHome > October 2014 - Volume 24 - Issue 5 > Screening for melanoma
Melanoma Research:
doi: 10.1097/CMR.0000000000000104
Review Articles

Screening for melanoma

Collins, Mary-Katharine M.a; Secrest, Aaron M.b; Ferris, Laura K.a

Collapse Box


Although melanoma is a deadly cancer that is rising in incidence, the USA does not have uniform guidelines for melanoma screening. Screening for melanoma requires no specialized equipment and has little associated morbidity. However, screening has the greatest impact when performed among patients with the highest risk for melanoma incidence and mortality. Screening lower-risk patients may result in prohibitively high costs, unnecessary biopsies of benign lesions, and decreased access to a dermatologic specialist for patients who are actually at a higher risk. We advocate targeting melanoma screening efforts toward those patients at high risk of developing and dying from melanoma, as well as toward those at-risk patients who are least likely to detect their own melanoma.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.